Document is current
Any future updates will be listed below
-
Authors
Buendía-Jiménez, Inmaculada
Matas-Ros, María
Garriga-Baraut, Teresa
Roger-Reig, Albert
Tabar-Purroy, Ana
,
Burchés Baixauli, Enrique
Cardona Dalh, Victoria
Castelló Carrascosa, José Vicente
Díaz Palacios, Miguel Ángel
Dordal Culla, Teresa
El-Qutob López, David
Ferrer Torres, Ángel
Hermida Clarena, Helena
Lara de la Rosa, María Pilar
Martínez Lezcano, Patricia
Pérez Formoso, José Luis
Torres Jaén, Maria José
Tortajada Girbés, Miguel
-
Funding
Funding for this research was provided by:
Centro para el Desarrollo Tecnológico Industrial
Probelte Pharma
- License Information
-
More Information
Article History
Received: 24 October 2023
Accepted: 10 May 2025
First Online: 28 May 2025
Declarations
:
: The IRB of the Virgen de la Arrixaca Universitary hospital acted as the trial’s coordinating ethics committee. The study protocol, version 1.1, was approved on September 7 th, 2021.
: All authors have read and approved this manuscript.
: Inmaculada Buendia-Jimenez and Maria Matas-Ros are employees at Probelte Pharma. Teresa Garriga-Baraut, Albert Roger-Reig and Ana Tabar-Purroy have received honoraria for consulting in allergy research from Probelte Pharma.
